These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 37762535)

  • 1. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants.
    Monsur MB; Shao G; Lv Y; Ahmad S; Wei X; Hu P; Tang S
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.
    Li ZH; Wang J; Xu JP; Wang J; Yang X
    Mil Med Res; 2023 Mar; 10(1):12. PubMed ID: 36895064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiplex gene editing and regulation techniques based on CRISPR/Cas system].
    Fan X; Wang J; Liang L; Liu R
    Sheng Wu Gong Cheng Xue Bao; 2023 Jun; 39(6):2449-2464. PubMed ID: 37401603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glance at genome editing with CRISPR-Cas9 technology.
    Barman A; Deb B; Chakraborty S
    Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research.
    Gutiérrez-Rodríguez A; Cruz-Fuentes CS; Genis-Mendoza AD; Nicolini H
    Braz J Psychiatry; 2023 May; 45(2):137-145. PubMed ID: 36753615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-based therapeutics: current challenges and future applications.
    Modell AE; Lim D; Nguyen TM; Sreekanth V; Choudhary A
    Trends Pharmacol Sci; 2022 Feb; 43(2):151-161. PubMed ID: 34952739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
    Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
    Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of Cas12a applications in bacteria.
    Meliawati M; Schilling C; Schmid J
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):2981-2990. PubMed ID: 33754170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in the genetic editing technologies: CRISPR-Cas and beyond.
    Mingarro G; Del Olmo ML
    Gene; 2023 Feb; 852():147064. PubMed ID: 36435506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.